An adjunctive management of depression program for difficult-to-treat depressed patients and their families

Depression and Anxiety

Volumn 27, Issue 1, 2010, Pages 27-34

  Ryan, Christine E ^a   Keitner, G I ^a   Bishop, S ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Depression; Family functioning; Mood disorders; Psychosocial functioning; Quality of life

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DYSTHYMIA; FAMILY FUNCTIONING; FEASIBILITY STUDY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR DEPRESSION; MALE; MANAGEMENT OF DEPRESSION PROGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DISEASE MANAGEMENT; DYSTHYMIC DISORDER; FAMILY CONFLICT; FAMILY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PILOT PROJECTS; PSYCHOTHERAPY, BRIEF; QUALITY OF LIFE; RECURRENCE; SELF CARE;

EID: 75749130269     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20640     Document Type: Article

References (37)

1. Keitner GI, Garlow S, Ryan CE, et al. A randomized, placebo-controlled trial of risperdone augmentation for patients with difficult-to-treat unipolar, nonpsychotic major depression. J Psychiatr Res 2009;43:205-214.
2. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurementsbased care in STAR*D implications for clinical practice. Am J Psychiatry 2006;163:28-40.
3. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241.
4. Kennedy N, Abbott R, Paykel ES. Longitudinal syndromal and subsyndromal symptoms after severe depression: 10-year follow-up study. Br J Psychiatry 2004;184:330-336.
5. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998;55:694-700.
6. Brodaty H, Luscombe G, Peisah C, et al. A 25-year longitudinal, comparison study of the outcome of depression. Psychol Med 2001;1347-1359.
7. Solomon DA, Leon AC, Endicott J, et al. Psychosocial impairment and recurrence of major depression. Compr Psychiatry 2004;45:423-430.
8. Paykel ES, Scott JD, Teasdale JD. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 1999;56:829-835.
9. Keller MB,McCullough JP, Klein DN. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-1470.
10. Friedman MA, Detweiler JB. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol-Sci Pr 2004;11:47-68.
11. Insel TR. Translating scientific opportunity into public health impact. Arch Gen Psychiatry 2009;66:128-133.
12. Keitner GI, Ryan CE, Solomon DA. Realistic expectations and a disease management model for depressed patients with persistent symptoms. J Clin Psychiatry 2006;67:1412-1421.
13. Glasgow RE, Funnell MM, Bonomi AE, et al. Self-management aspects of the improving chronic illness care breakthrough series: implementation with diabetes and heart failure teams. Ann Behav Med 2002;24:80-87.
14. Badamgarav E, Weingarten SR, Henning JM, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry 2003;160:2080-2090.
15. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 2003;26:1-7.
16. Goldstein MG. Supporting self-management to improve diabetes care. Med Health R I 2004;87:46-49.
17. Keitner GI, Solomon DA, Ryan CE. STAR*D: Have we learned the right lessons? Am J Psychiatry 2008;165:1-133.
18. Moras J, Telfer LA, Barlow DH. Efficacy and specific effects data on new treatments: a case study strategy with mixed anxietydepression. J Consult Clin Psychol 1993;61:412-420.
19. Carroll KM, Rounsaville BJ. Efficacy and effectiveness in developing treatment manuals. In: Nezu AM, Nezu CM, editors. Evidence-Based Outcome Research: A Practical Guide to Conducting Randomized Controlled Trials for Psychosocial Interventions. New York, NY: Oxford University Press; 2008:219-244.
20. Nock MK, Janis IB, Wedig MM. Research designs. In: Nezu AM, Nezu CM, editors. Evidence-Based Outcome Research: A Practical Guide to Conducting Randomized Controlled Trials for Psychosocial Interventions, New York, NY: Oxford University Press; 2008:201-218.
21. Fava GA, Ruini C, Belaise C. The concept of recovery in major depression. Psychol Med 2007;37:307-317.
22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
23. Beck A, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry, 1961;4:561-571.
24. Keller MB. Under treatment of major depression. Psychopharmacol Bull 1988;24:75-80.
25. Sackheim HA. The definition and meaning of treatment resistant depression. J Clin Psychiatry 2001;62:10-17.
26. Endicott J, Nee J, Harrison W, et al. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmaco Bull 1993;29:321-326.
27. Ryff CD, Singer B. Psychological well-being: meaning, measurement, and implications for psychotherapy research. Psychother Psychosom 1996;65:14-23.
28. Epstein NB, Baldwin LM, Bishop DS. The McMaster family assessment device. J Marital Fam Ther 1983;9:171-180.
29. Ryan CE, Epstein NB, Keitner GI, et al. Evaluating and Treating Families: The McMaster Approach. New York: Routledge Taylor & Francis Group; 2005.
30. Rush AJ, Thase M, Dube S. Research issues in study of difficultto-treat depression. Biol Psychiatry 2003;53:743-753.
31. Klein N, Sacher J, Wallner H, et al. Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics. CNS Spectrums 2004;9:823-832.
32. Souery D, Lipp O, Massat I, et al. The characterization and definition of treatment-resistant mood disorders in treatment-resistant mood disorders In: Amsterdam JD, Hornig M, Nierenberg AA, editors. Treatment-Resistant Mood Disorders. United Kingdom: Cambridge University Press.
33. Kennedy N, Aykel ES. Treatment and response in refractory depression: results from a specialist affective disorders service. J Affect Disord 2004;81:49-53.
34. Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Br J Psychiatry 2002;181:284-294.
35. Engel GI. The need for a new medical model: a challenge for biomedicine. Science 1977;196:4286:129-136.
36. Epstein NB, Bishop DS, Baldwin LM. McMaster model of family functioning: a view of the normal family. In: Walsh F, editor. Normal Family Process. 1st ed. New York: Guilford Press; 1982:115-141.
37. Ryff CD. Happiness is everything, or is it? Explorations on the meaning of psychological well-being. J Pers Soc Psychol 1989;57:1069-1081.